Skip to main content

Don’t invest unless you’re prepared to lose all your money.
These are high-risk investments and you are unlikely to be protected if something goes wrong.
Take 2 mins to learn more.


Keep up to date with what is going on at Deepbridge, our investee companies and other exciting news.

Important Notice: Investments in unquoted companies carries high risks and investors could lose all funds invested. Investors should not invest if capital is required in the near term. No established market exists for the trading of shares in private companies, making it difficult to sell shares. The value of tax reliefs depend on personal circumstances and may be subject to change in the future. The availability of tax reliefs depends on the Company invested in maintaining its qualifying status. Past performance is not a guide to the future performance of an investment, and investors are encouraged to take independent legal, tax and financial advice before considering an investment.
Deepbridge Sponsors Racing Driver Seb Morris

4th April 2022

Deepbridge are pleased to announce that we have sponsored Seb Morris in the Porsche Carrera Cup GB 2022, which continues to be the fastest single…

Full article
RDVault Wins Tech Nation's Rising Stars Competition

31st March 2022

RDVault, an investee company within the Deepbridge Life Sciences EIS portfolio, has won Tech Nation's fourth Rising Stars competition, which…

Full article
Building Back Better: Opportunities For Advisers

17th March 2022

Andrew Aldridge, Partner & Head of Marketing at Deepbridge, recently spoke with Professional Adviser to discuss the UK Government's current…

Full article
ENSO Announce Strategic Partnership With Wastefront

14th March 2022

Wastefront, which is behind plans to build a £100m tyre recycling plant at The Port of Sunderland, has revealed a partnership with one of Deepbridge'…

Full article
GenoME Diagnostics Awarded £50K To Aid Early Detection Of Ovarian Cancer

12th March 2022

GenoME Diagnostics, an investee company within Deepbridge's Life Sciences SEIS portfolio has recently won a £50,000 award that is to be given to…

Full article
Behind The Deepbridge's Life Sciences Portfolio

10th March 2022

One of Deepbridge Capital's Life Sciences Investment Managers, Ben Carter, recently spoke to IFA Magazine about the role of an investment manager and…

Full article
Ocutec Ltd Secure £1.5M Seed Funding Round

3rd March 2022

Ocutec, which is part of the Deepbridge Technology Growth EIS portfolio, has recently secured £1.5 million in a seed funding round that was led by…

Full article
Tax Year End Webinar – What did we learn?

1st March 2022

Summary of the Deepbridge Explore Webinar  Simon Tutton, Regional Director (South West England and South Wales), Deepbridge Capital The end of the…

Full article
VoxSmart Wins Award at the TradingTech Insight Awards 2022

28th February 2022

VoxSmart Ltd, which is part of the Deepbridge Technology Growth EIS portfolio, has recently been selected by public vote as the winner of the 'Best…

Full article
FluoretiQ Closes £1.1 Million Funding Round

21st February 2022

  FluoretiQ, which is part of the Deepbridge Life Sciences EIS portfolio, as of February 21st 2022, has announced the completion of a £1.1 million,…

Full article
How EIS Can Reduce Client Income Tax Bills

19th February 2022

  Andrew Aldridge, Partner and Head of Marketing at Deepbridge, recently spoke with Money Marketing to share his thoughts regarding how the…

Full article
Deepbridge Expands Innovation SEIS Fund

17th February 2022

As of 16th February 2022, Deepbridge Capital is opening a new £1 million tranche of the Deepbridge Innovation SEIS fund.  The Deepbridge Innovation…

Full article